Observational study of the association of first insulin type in uncontrolled type 2 diabetes with macrovascular and microvascular disease.

To compare the risk of vascular disease, HbA1c and weight change, between first prescribed insulins in people with type 2 diabetes.People included in THIN United Kingdom primary care record database who began insulin (2000-2007) after poor control on oral glucose-lowering agents (OGLD) were grouped...

Full description

Bibliographic Details
Main Authors: Gillian C Hall, Alex D McMahon, Dawn Carroll, Philip D Home
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3498210?pdf=render
_version_ 1818696240843456512
author Gillian C Hall
Alex D McMahon
Dawn Carroll
Philip D Home
author_facet Gillian C Hall
Alex D McMahon
Dawn Carroll
Philip D Home
author_sort Gillian C Hall
collection DOAJ
description To compare the risk of vascular disease, HbA1c and weight change, between first prescribed insulins in people with type 2 diabetes.People included in THIN United Kingdom primary care record database who began insulin (2000-2007) after poor control on oral glucose-lowering agents (OGLD) were grouped by the number of OGLDs in their treatment regimen immediately before starting insulin (n = 3,485). Within OGLD group, Cox regression compared macrovascular (all-cause mortality, myocardial infarction, acute coronary syndrome and stroke) and microvascular disease (peripheral neuropathy, nephropathy, and retinopathy) between insulin type (basal, pre-mix or Neutral Protamine Hagedorn, NPH) while ANCOVAs compared haemoglobin A(1c) (HbA(1c)) and weight change.Mean follow-up was 3.6 years. Rates of incident macrovascular events were similar when basal insulin was compared to pre-mix or NPH, adjusted hazard ratio versus basal: pre-mix 1.08 (95% CI 0.73, 1.59); NPH 1.00 (0.63, 1.58) after two OGLDs, and pre-mix 0.97 (0.46, 2.02); NPH 0.77 (0.32, 1.86) after three OGLDs. An increased risk of microvascular disease in NPH versus basal after 3 OGLDs, adjusted hazard ratio 1.87 (1.04, 3.36), was not seen after two agents or in comparisons of basal and pre-mix. At one year, after two OGLDs, weight increase was less with basal compared with pre-mix. After three OGLDs, mean HbA(1c) had reduced less in basal versus pre-mix or NPH at 6-8 and at 9-11 months, and versus pre-mix at 12-14 months.We found no difference in the risk of macrovascular events between first insulins in the medium term when started during poor glycaemia control. The increased risk of microvascular events with NPH warrants further study. In certain groups, first use of basal insulin was associated with less gain in weight and decrease in HbA(1c) compared to other insulins.
first_indexed 2024-12-17T13:58:14Z
format Article
id doaj.art-dddc88494b044d249add95679c58a015
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-17T13:58:14Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-dddc88494b044d249add95679c58a0152022-12-21T21:45:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01711e4990810.1371/journal.pone.0049908Observational study of the association of first insulin type in uncontrolled type 2 diabetes with macrovascular and microvascular disease.Gillian C HallAlex D McMahonDawn CarrollPhilip D HomeTo compare the risk of vascular disease, HbA1c and weight change, between first prescribed insulins in people with type 2 diabetes.People included in THIN United Kingdom primary care record database who began insulin (2000-2007) after poor control on oral glucose-lowering agents (OGLD) were grouped by the number of OGLDs in their treatment regimen immediately before starting insulin (n = 3,485). Within OGLD group, Cox regression compared macrovascular (all-cause mortality, myocardial infarction, acute coronary syndrome and stroke) and microvascular disease (peripheral neuropathy, nephropathy, and retinopathy) between insulin type (basal, pre-mix or Neutral Protamine Hagedorn, NPH) while ANCOVAs compared haemoglobin A(1c) (HbA(1c)) and weight change.Mean follow-up was 3.6 years. Rates of incident macrovascular events were similar when basal insulin was compared to pre-mix or NPH, adjusted hazard ratio versus basal: pre-mix 1.08 (95% CI 0.73, 1.59); NPH 1.00 (0.63, 1.58) after two OGLDs, and pre-mix 0.97 (0.46, 2.02); NPH 0.77 (0.32, 1.86) after three OGLDs. An increased risk of microvascular disease in NPH versus basal after 3 OGLDs, adjusted hazard ratio 1.87 (1.04, 3.36), was not seen after two agents or in comparisons of basal and pre-mix. At one year, after two OGLDs, weight increase was less with basal compared with pre-mix. After three OGLDs, mean HbA(1c) had reduced less in basal versus pre-mix or NPH at 6-8 and at 9-11 months, and versus pre-mix at 12-14 months.We found no difference in the risk of macrovascular events between first insulins in the medium term when started during poor glycaemia control. The increased risk of microvascular events with NPH warrants further study. In certain groups, first use of basal insulin was associated with less gain in weight and decrease in HbA(1c) compared to other insulins.http://europepmc.org/articles/PMC3498210?pdf=render
spellingShingle Gillian C Hall
Alex D McMahon
Dawn Carroll
Philip D Home
Observational study of the association of first insulin type in uncontrolled type 2 diabetes with macrovascular and microvascular disease.
PLoS ONE
title Observational study of the association of first insulin type in uncontrolled type 2 diabetes with macrovascular and microvascular disease.
title_full Observational study of the association of first insulin type in uncontrolled type 2 diabetes with macrovascular and microvascular disease.
title_fullStr Observational study of the association of first insulin type in uncontrolled type 2 diabetes with macrovascular and microvascular disease.
title_full_unstemmed Observational study of the association of first insulin type in uncontrolled type 2 diabetes with macrovascular and microvascular disease.
title_short Observational study of the association of first insulin type in uncontrolled type 2 diabetes with macrovascular and microvascular disease.
title_sort observational study of the association of first insulin type in uncontrolled type 2 diabetes with macrovascular and microvascular disease
url http://europepmc.org/articles/PMC3498210?pdf=render
work_keys_str_mv AT gillianchall observationalstudyoftheassociationoffirstinsulintypeinuncontrolledtype2diabeteswithmacrovascularandmicrovasculardisease
AT alexdmcmahon observationalstudyoftheassociationoffirstinsulintypeinuncontrolledtype2diabeteswithmacrovascularandmicrovasculardisease
AT dawncarroll observationalstudyoftheassociationoffirstinsulintypeinuncontrolledtype2diabeteswithmacrovascularandmicrovasculardisease
AT philipdhome observationalstudyoftheassociationoffirstinsulintypeinuncontrolledtype2diabeteswithmacrovascularandmicrovasculardisease